Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424554
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2007-01-18
Brief Title:
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas P04602 AM1 Completed
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2010-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-18
First Submit QC Date:
January 18 2007
Study First Post Date:
2007-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-06-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL